CAS: 1353550-13-6 - Olmutinib
Formel:C26H26N6O2S
InChl:InChI=1S/C26H26N6O2S/c1-3-23(33)27-19-5-4-6-21(17-19)34-25-24-22(11-16-35-24)29-26(30-25)28-18-7-9-20(10-8-18)32-14-12-31(2)13-15-32/h3-11,16-17H,1,12-15H2,2H3,(H,27,33)(H,28,29,30)
InChI Key:InChIKey=FDMQDKQUTRLUBU-UHFFFAOYSA-N
SMILES:O=C(C=C)NC=1C=CC=C(OC2=NC(=NC=3C=CSC23)NC4=CC=C(C=C4)N5CCN(C)CC5)C1
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
2-Propenamide, N-[3-[[2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]thieno[3,2-d]pyrimidin-4-yl]oxy]phenyl]- REF: AN-AG0021TBCAS: 1353550-13-6 | 98% | Nachfragen | Mo 10 Jun 24 | |
Olmutinib REF: TM-T6918CAS: 1353550-13-6 | 99.27% | 39,00 €~454,00 € | Mo 17 Jun 24 | |
Olmutinib REF: 3D-DEC55013CAS: 1353550-13-6 | Min. 95% | Nachfragen | Mo 22 Jul 24 |
2-Propenamide, N-[3-[[2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]thieno[3,2-d]pyrimidin-4-yl]oxy]phenyl]-
Ref: AN-AG0021TB
1g | Nachfragen | ||
5mg | 56,00 € | ||
10mg | 70,00 € | ||
50mg | 187,00 € | ||
100mg | 228,00 € | ||
250mg | 511,00 € |
Olmutinib
- Inhibitoren
- Angiogenese
- EGFR
- BTK
- Mehr Kategorien anzeigen
- JAK/STAT-Signalweg
- Tyrosinkinase/Adaptoren
- PI3K/Akt/mTOR-Signalgebung
Ref: TM-T6918
2mg | 39,00 € | ||
5mg | 56,00 € | ||
10mg | 87,00 € | ||
25mg | 134,00 € | ||
50mg | 176,00 € | ||
100mg | 276,00 € | ||
200mg | 454,00 € | ||
1ml*10 (DMSO) | 58,00 € |
Olmutinib
Ref: 3D-DEC55013
5mg | Nachfragen | ||
10mg | Nachfragen | ||
25mg | Nachfragen | ||
50mg | Nachfragen | ||
100mg | Nachfragen |